Acutus Medical, Inc. (AFIB)
$1.58
-0.06 (-3.66%)
Rating:
Recommendation:
-
| Symbol | AFIB |
|---|---|
| Price | $1.58 |
| Beta | 0.654 |
| Volume Avg. | 0.61M |
| Market Cap | 44.954M |
| Shares () | - |
| 52 Week Range | 0.48-2.49 |
| 1y Target Est | - |
| DCF Unlevered | AFIB DCF -> | |
|---|---|---|
| DCF Levered | AFIB LDCF -> | |
| ROE | -111.34% | Strong Sell |
| ROA | -75.02% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 98.38% | Buy |
| P/E | - | |
| P/B | 0.78 | Buy |
Latest AFIB news
About
Download (Excel)Mr. R. Scott Huennekens M.B.A., CPA
Healthcare
Medical Devices
NASDAQ Global Select
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.